Renaissance IPO ETF (IPO) News Today $44.09 -1.39 (-3.06%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$43.90 -0.19 (-0.42%) As of 02/21/2025 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartHeadlinesHoldingsOwnershipRatings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period IPO Roundup: Anbio Biotechnology, Wellgistics Health and moreFebruary 18, 2025 | msn.comSPACs are back with a vengeance. What could possibly go wrong?February 18, 2025 | msn.comSailPoint’s dull debut did little to loosen the stuck IPO window, expert saysFebruary 14, 2025 | msn.comIPO Roundup: Karman Space & Defense, Aardvark Therapeutics and moreFebruary 12, 2025 | msn.comKestra Medical, wearable device maker, files for $100M IPOFebruary 12, 2025 | msn.comIPO Roundup: Titan America, Aureus Greenway and moreFebruary 3, 2025 | msn.comExchange Traded Concepts Trust Range Nuclear Renaissance Index ETF (ARCA:NUKZ), Short Interest ReportFebruary 1, 2025 | benzinga.comMaze Therapeutics stock hugs flat line following $140M IPOJanuary 31, 2025 | msn.comObesity drug developer Aardvark files for IPOJanuary 24, 2025 | msn.comIPO Roundup: Toppoint, Venture Global and moreJanuary 21, 2025 | msn.comSailPoint Parent files for $100M IPOJanuary 17, 2025 | msn.comOdyssey Therapeutics files for $100M IPOJanuary 17, 2025 | msn.comObesity drug developer Metsera files for $100M IPOJanuary 13, 2025 | msn.comKidney disease drug developer Maze files for $100M IPOJanuary 9, 2025 | msn.comMedtech test developer Anbio files for $9M US IPOJanuary 3, 2025 | msn.comIPO Roundup: Cre8 Enterprise, Diginex and moreDecember 30, 2024 | msn.comMedline files for IPO, valuation could hit $50B: reportDecember 20, 2024 | msn.comIPO Roundup: Health in Tech, Leishen Energy and moreDecember 17, 2024 | msn.comA Tech Renaissance Could Offer Enticing Opportunities In Direxion's QQQU, QQQD ETFsDecember 11, 2024 | benzinga.comServiceTitan IPO raises price on deal demand and appetite for new issuersDecember 10, 2024 | msn.comIPO Roundup: ServiceTitan, Jackson Acquisition II and moreDecember 9, 2024 | msn.comIPO Roundup: Fast Track Group, MasterBeef and moreDecember 5, 2024 | msn.comServiceTitan’s planned IPO could come with a more than $5 billion valuationDecember 4, 2024 | msn.com7 Upcoming IPOs That Could Soar in 2025November 27, 2024 | msn.comIPO Roundup: Pony AI, ServiceTitan and moreNovember 25, 2024 | msn.comCannabis company Papa Medical files for $27.6M IPONovember 23, 2024 | msn.comMedical supplies giant Medline reportedly eyeing $5B IPO in 2025November 22, 2024 | msn.comIPO Roundup: Pony AI, Brazil Potash and moreNovember 18, 2024 | seekingalpha.comIPO: Favorable Capital Markets In 2025 Not Yet A Tailwind (Rating Downgrade)November 17, 2024 | seekingalpha.comSepterna proposes terms for upsized $175M IPOOctober 22, 2024 | msn.comIPO Roundup: Ingram Micro Holdings, Peak Resources and moreOctober 21, 2024 | msn.comLower Rates, Surging Stock Market Fail To Ignite US IPO MarketOctober 17, 2024 | barrons.comCuranex, botanical drug developer, files for $10M IPOOctober 17, 2024 | msn.comIngram Micro sets IPO terms, which could value the IT company at $5.4 billionOctober 15, 2024 | msn.comCeribell’s stock indicates up 35% in trading debut after pricing IPO at top of rangeOctober 11, 2024 | msn.comWednesday's big stock stories: What’s likely to move the market in the next trading sessionOctober 9, 2024 | msn.comIPO market braces for nine deals this week, led by early-education provider KinderCareOctober 7, 2024 | marketwatch.comU.S. IPO market braces for nine deals this week, led by early-education provider KinderCareOctober 7, 2024 | msn.comSepterna, hypoparathyroidism drug developer, files for $100M IPOOctober 3, 2024 | msn.comETFs in Focus as Cerebras Systems Plans IPO Amid AI Chip BoomOctober 3, 2024 | finance.yahoo.comMBX Biosciences sets IPO terms with plans to raise up to $136 millionSeptember 9, 2024 | msn.comIPO Roundup: Bicara Therapeutics, Kairos Pharma and moreSeptember 9, 2024 | seekingalpha.comChina Renaissance shares plunge after 17-month suspension, former chairman's detentionSeptember 9, 2024 | reuters.comStock Market Today: Dow down 300 points as investors seek 'clearer read' on labor market from Friday jobs reportSeptember 6, 2024 | marketwatch.comThe floodgates on the IPO market are unlikely to open before year-endSeptember 6, 2024 | msn.comIPO Roundup: Cuprina Holdings, Galaxy Payroll and moreAugust 27, 2024 | seekingalpha.comIPO Roundup: WeRide, Reitar Logtech and moreAugust 19, 2024 | msn.comU.S. IPO Weekly Recap: WeRide Reschedules While 6 New Filers Join The PipelineAugust 17, 2024 | seekingalpha.comWhat's Going On With Nu Holdings Stock Today?August 14, 2024 | msn.comTexas Tech opens new academic sciences building for research, interdisciplinary collaborationAugust 11, 2024 | msn.com Get Renaissance IPO ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for IPO and its competitors with MarketBeat's FREE daily newsletter. Email Address IPO Media Mentions By Week IPO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPO News Sentiment▼-0.080.70▲Average News Sentiment IPO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPO Articles This Week▼21▲IPO Articles Average Week Get Renaissance IPO ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for IPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies iShares Self-Driving EV and Tech ETF News Goldman Sachs Future Tech Leaders Equity ETF News Fidelity Disruptive Technology ETF News Humankind US Stock ETF News Amplify Etho Climate Leadership U.S. ETF News Amplify Alternative Harvest ETF News WisdomTree Cybersecurity Fund News ROBO Global Artificial Intelligence ETF News Fidelity Crypto Industry and Digital Payments ETF News iShares MSCI Global Sustainable Development Goals ETF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:IPO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renaissance IPO ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Renaissance IPO ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
